PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93023C00052Conduct clinical development of a compound — Aligos Therapeutics Inc

Aligos Therapeutics Inc holds $11.3M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 7 offers. Set-aside status: Unrestricted. Recompete timing centers on the Dec 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Niaid
Awarding office
Aligos Therapeutics Inc
Recipient
Dec 31, 2026
PoP end
$11.3M
Obligated
$11.3M
Potential
541715
NAICS
AN12
PSC
Unrestricted
Set-aside
7 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75N93023C00052
AgencyNational Institutes Of Health Niaid
Awarding officeNational Institutes Of Health Niaid
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentAligos Therapeutics Inc
CAGE96ED3
UEIED19ABDRLV29
NAICS541715
PSCAN12
Place of performanceSOUTH SAN FRANCISCO CA
Pricing typeCost Plus Fixed Fee
Extent competedFull And Open Competition
Related solicitationHHS-NIH-NIAID-BAA2023-01
PoP startSep 22, 2023
PoP end (current)Dec 31, 2026
Obligated$11.3M
Current value$11.3M
Potential value$11.3M

TO CONDUCT CLINICAL DEVELOPMENT OF A COMPOUND FOR THE TREATMENT OF COVID-19. is a federal Unrestricted award for National Institutes Of Health Niaid held by Aligos Therapeutics Inc. Estimated value $11.3M ($11.3M obligated). Current period of performance ends Dec 31, 2026. Last award drew 7 bidders. Place of performance: SOUTH SAN FRANCISCO CA. Related solicitation HHS-NIH-NIAID-BAA2023-01.

TO CONDUCT CLINICAL DEVELOPMENT OF A COMPOUND FOR THE TREATMENT OF COVID-19.

Recompete timing

Public
● Expiring in 95 days

Current PoP ends Dec 31, 2026 (95 days remaining). Agencies typically plan 12–18 months ahead — at 3.1 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75N93023C00052? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Aligos Therapeutics Inc — $11.3M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$11.3M · 100% of firm total
Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N93023C00052?

75N93023C00052 (Conduct clinical development of a compound) is a National Institutes Of Health Niaid award with a potential value of $11.3M, currently held by Aligos Therapeutics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N93023C00052?

National Institutes Of Health Niaid awarded 75N93023C00052 to Aligos Therapeutics Inc (potential $11.3M).

Who is the incumbent on 75N93023C00052?

Aligos Therapeutics Inc is the incumbent with $11.3M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.

When does Aligos Therapeutics Inc’s 75N93023C00052 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N93023C00052? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N93023C00052